The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow IPOs

By The Online Investor Staff, updated Thu., Mar. 5, 5:21 AM

Slide #1. Bellerophon Therapeutics Initial Public Offering

Company: Bellerophon Therapeutics
Proposed Symbol: BLPH
Shares Offered: 5,000,000
Price Per Share: $12.00
Over-Allotment: 750,000
Description: Bellerophon Therapeutics announced today the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the shares in the offering are being sold by Bellerophon. In addition, Bellerophon has granted the underwriters an option to purchase up to 750,000 additional shares of common stock at the public offering price, less the underwriting discount. Bellerophon's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the ticker symbol "BLPH" on February 13, 2015. The offering is expected to close on February 19, 2015, subject to customary closing conditions.

IPOs: Bellerophon Therapeutics

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Invitae Corporation                     NVTA      
Avenue Financial Holdings, Inc.         AVNU      
Sutherland Asset Management Corporation SLD       
InfraREIT, Inc.                         HIFR      
Columbia Pipeline Partners LP           CPPL      
Zosano Pharma Corporation               ZSAN      
Euronav NV                              EURN      
Ascendis Pharma A/S                     ASND      
Flex Pharma, Inc.                       FLKS      
Entellus Medical, Inc.                  ENTL      
Presbia PLC                             LENS      
Easterly Government Properties, Inc.    DEA       
PGI Specialty Materials, Inc.           T.B.D.    
Inovalon                                INOV      
Bellerophon Therapeutics                BLPH      

March 5, 2015    5:21 AM Eastern

IPOs | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.